|
|
|
|
|
by phnk
2869 days ago
|
|
> depression, anxiety, introversion, etc. That's a whole array of pathologies and symptoms, for which there is no single pharmacological solution. Many comments in this thread are over-standardising mental illness as well as the (supervised administration) therapy presented in the linked article, which is about much more than dosage and frequency. On top of that, the patient in the article expresses many specificities that are unlikely to be matched by most patients. This is, to me, the first negative aspect of banning a drug -- it suppressed 99% of the potential evidence base and replaces it with poor 'SWIM-based' anecdotes. |
|